QuantumSpace AI Launches QLens for U.S. Clinicians

The visual intelligence company will debut its healthcare products at three major U.S. medical events as it enters a new stage of growth.

NEW YORK, Oct. 15, 2026 — QuantumSpace AI, the AI-powered computer vision company, announced today that it is delivering its innovation solutions into the hands of clinicians for the first time. The company will officially present QLens, its first dedicated healthcare product, at three major U.S. medical events this fall:AAO 2026 in New Orleans, AAO-HNSF Annual Meeting & OTO EXPO in Los Angeles, and RSNA 2026 in Chicago.

The presentations mark a significant step for QuantumSpace AI : the transition of its core visual intelligence technology from research infrastructure into a market-facing product designed for real clinical use.
“QLens marks a turning point for QuantumSpace AI, bringing years of research into the hands of clinicians,” said Francesco Rocchi, COO of QuantumSpace AI. “And this is just the beginning. We’re building scalable technology with the potential to transform how visual information is understood across medical specialties and beyond.”

QLens addresses a common challenge in medical imaging: understanding how a patient’s condition changes over time. The technology aligns and compares images acquired at different moments, helping clinicians identify, localize and measure meaningful changes while keeping interpretation and medical decision-making firmly in the hands of the physician.

QuantumSpace AI will introduce QLens to the ophthalmology community at AAO 2026 in New Orleans. The company will then bring the technology to Los Angeles, to demonstrate its application in ENT and laryngeal imaging at the AAO-HNSF Annual Meeting & OTO EXPO, before presenting it to the broader radiology and medical imaging community at RSNA 2026 in Chicago.

These applications of QuantumSpace AI’s technology for three medical specialties highlight its versatility: QLens was not developed for a single medical field, but around the broader challenge of making visual information captured over time truly comparable. The product is entering the market with the support of experienced clinicians, including Dr. Yosef (Joe) Krespi, world renowned Otolaryngologist and inventor in New York. Dr. Krespi, who has authored more than 180 scientific publications, edited four medical textbooks and contributed to more than 60 book chapters, will join QuantumSpace AI during its U.S. event series and engage directly with physicians as they experience QLens.

“In medicine, a single image only tells part of the story. Understanding how things change over time is often just as important,” said Dr. Krespi. “Technologies like QLens have the potential to make those changes easier to recognize and interpret, giving physicians the digital tools to support their clinical judgment.”

About QuantumSpace AI

QuantumSpace AI is a technology company specializing in AI computer vision and advanced visual intelligence solutions that transform images into structured, actionable data. Our software empowers organizations in a wide range of industries to monitor change, extract meaningful insights, and make decisions grounded in reliable, measurable results while keeping track of the status of their products.
QuantumSpace offers purpose-built tools for healthcare, energy, industrial infrastructure, aerospace, art, and collectibles, among others. For more information, visit quantumspace.ai